Cardiac Electrophysiology Clinics provides you with practical, hands-on advice on the evaluation and management of patients with heart rhythm disorders. Each issue provides expert, state-of-the-art discussions on a single topic relevant to your practice. You'll find clear, comprehensive coverage on valuable topics such as sudden cardiac death, diagnostic evaluation of arrhythmias, advances in arrhythmia analysis, arrhythmias in special populations, antiarrhythmic drug therapy, cardiac pacing and defibrillation, genetics and pharmacogentics, and much more. Cardiac Electrophysiology Clinics is published four times a year—March, June, September, and December.
Published four times a year—in February, May, August, and November— Cardiology Clinics updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Tailored to meet the needs of those in the field of cardiology, each issue focuses on a single cardiology topic, including acute coronary syndromes/cardiac emergencies, coronary artery disease, heart failure, heart rhythm disorders, and much more.
A Journal of Basic, Clinical and Applied Cardiovascular Science The Official Journal of the Society for Cardiovascular PathologyCardiovascular Pathology is a bimonthly journal that presents articles on topics covering the entire spectrum of cardiovascular disease. The Journal's primary objective is to publish papers on disease-oriented morphology and pathogenesis from clinicians and scientists in the cardiovascular field. Subjects covered include cardiovascular biology, prosthetic devices, molecular biology and experimental models of cardiovascular disease.For more information about the Society for Cardiovascular Pathology (SCVP), please visit their website at URL: http://scvp.net .Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: https://service.elsevier.com
including Molecular Interventions Cardiovascular Revascularization Medicine (CRM) is an international, English-language, multidisciplinary, peer-reviewed journal that publishes original laboratory and clinical investigations related to revascularization therapies in cardiovascular medicine. CRM publishes 12 regular print issues and a supplemental issue each year.The journal is indexed on Index Medicus and MEDLINE®/PubMed®.The journal's location in Washington, DC, gives it an advantage in reporting on regulatory issues as they pertain to interventional cardiology and structural heart disease. The journal is read by cardiologists, interventional cardiologists, structural heart interventionalists, vascular physicians, healthcare regulators, industry, fellows in training, and innovators around the globe.CRM is also the official journal of the Cardiovascular Research Technologies (CRT) meeting, a premier event that brings together about 3,000 interventional cardiologists annually to discuss cutting-edge research and innovations. Attendees are encouraged to submit papers based on abstracts, interesting cases, late-breaking trials, and innovations presented at the meeting that impact interventional cardiologists' practice. The journal structures its content to reflect topics based on each track of the CRT meeting: Complex Coronary, Valve and Structural, Endovascular, Imaging and Physiology, Atherosclerosis, Cardiogenic Shock, Technology and Innovation, Regulatory and Healthcare Policy, and Innovations.CRM publishes articles related to preclinical and clinical work, including pharmacological interventions, and restenosis management; and treatment, including experiments conducted in human subjects, laboratory animals, and in vitro. Specific areas of interest include percutaneous angioplasty in coronary and peripheral arteries, intervention in structural heart disease, cardiovascular surgery, congenital heart disease, coronary heart disease, genetics and translational science, health services and outcomes research, invasive imaging, regulatory and health policy, technology and innovation, and vascular medicine.The journal's nearest competitors are JACC: Cardiovascular Interventions, Circulation: Cardiovascular Interventions, and EuroIntervention.CRM will consider all articles describing clinical trials and translational research (i.e., those that unite the clinic with the laboratory). The journal publishes original articles, research letters, reviews, editorials, and special features. Original articles that address any aspect of cardiovascular revascularization or structural intervention are invited. Letters to the editor, trial design papers, and interesting images are encouraged. The journal's peer-review process is single-blind.
Caring for the Ages is the official newspaper of AMDA and provides post-acute and long-term care professionals with timely and relevant news and commentary about clinical developments and about the impact of health care policy on long-term care medicine.
Cell Calcium covers the field of calcium metabolism and signalling in living systems, from aspects including inorganic chemistry, physiology, molecular biology and pathology. Topic themes include:Roles of calcium in regulating cellular events such as apoptosis, necrosis and organelle remodellingInfluence of calcium regulation in affecting health and disease outcomes
Cellular Signalling publishes original research describing fundamental and clinical findings on the mechanisms, actions and structural components of cellular signalling systems in vitro and in vivo.Cellular Signalling aims at full length research papers defining signalling systems ranging from microorganisms to cells, tissues and higher organisms.Cellular Signalling strives to offer a fair and fast peer-review process with a single round of revisions. Reviews are by invitation-only. Short Reports are not accepted.
Official Publication of the American College of Chest Physicians.CHEST® is committed to advancing the care of patients served by multidisciplinary clinicians across pulmonary, critical care, and sleep medicine through the publication of clinical research relevant to today's challenges and reflecting advances on the horizon. To provide context in a fast-changing landscape, CHEST also incorporates review articles, offers commentaries, and fosters debate on emerging controversies. CHEST applies strict peer review standards to ensure the scientific rigor and publishes all content online within two weeks of acceptance.
Child and Adolescent Psychiatric Clinics of North America updates you on the latest trends in patient management; keeps you up to date on the newest advances; and provides a sound basis for choosing treatment options. Each issue focuses on a single topic in child and adolescent psychiatry and is presented under the direction of an experienced guest editor.
International Journal of Clinical Chemistry and Diagnostic Laboratory Medicine The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal's scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.